LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

2019: Large scale microbial production of next generation, zero-calorie, non-artificial EVERSWEET™ Stevia sweetener

02/07/2021

Nominated by: DSM

Organisation in nomination: DSM, Cargill

Most people consume too many calories that originate from sugar, increasing the risk of being overweight or developing obesity, both of which in turn are risk-factors for non-communicable diseases including diabetes, cardio-vascular disease and cancers.

Science has been searching for sugar alternatives for many decades, and biotechnology has built upon the discovery of Stevia, a natural sweetener first extracted from the leaves of Stevia rebaudiana. Stevia leaves have been used for more than 1500 years in its native Brazil and Paraguay and used as a sweetener in countries such as Japan since the early 1970s. However, Stevia plants are a scarce resource, risking extinction in the wild.  In addition, the sweetest components, rebaudioside M and D, are present in Stevia and its extracts in very low quantities. Thus, alternative methods of production have long been sought.

Companies have worked towards engineering yeast to produce rebaudioside M and D identical to those found in the Stevia plant, and able to do it economically, scaleably, and sustainably.

In 2019, DSM and Cargill joined forces to form the joint venture Avansya and launched large-scale manufacturing of its EVERSWEET™ sweetener, using the yeast strain Yarrowia lipolytica.  Development work resulted in high productivity, consistent quality, economic viability and significant reduced environmental impact compared to traditional extraction or bio-conversion.

The EVERSWEET™ sweetener experienced rapid commercial take-up for use in food products, including drinks, dairy, cereals and bars, plus baking and alcoholic drinks.

Regulatory dossiers have now been approved in US, Mexico, Canada and a number of countries in Asia, and regulatory approval is awaited in Europe as well as other territories as part of global market access, for a significant advance in biotechnology-derived healthier food and drinks with reduced environmental footprint. This strongly meets societal and health demands for a non-artificial, zero calorie, sustainably produced sweetener at a cost that is competitive to sugar within industrial scale production.

Life Cycle Analysis of EVERSWEETTM compared to alternatives, demonstrated a 59% reduction in carbon footprint, 70% reduction in land use and 49% reduction in depletion of resources.

 

Back to the list.

Share
Communications Team
Communications Team
EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.